Induction of therapeutic abortion with intra-amniotically administered prostaglandin F 2  . A comparison of three repeated-injection dose schedules.
D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D000653:Amniotic Fluid; D001772:Blood Cell Count; D001827:Body Height; D001835:Body Weight; D002584:Cervix Uteri; D003967:Diarrhea / Q000150:complications; D004305:Dose-Response Relationship, Drug; D004716:Endometritis / Q000150:complications; D005260:Female; D005334:Fever / Q000150:complications; D005865:Gestational Age; D006801:Humans; D010146:Pain; D010298:Parity; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000150:complications; D014839:Vomiting / Q000150:complications
D011453:Prostaglandins